Georgia Plays Key Role in the Large-Scale Manufacturing of Cell-Based Therapeutics
July 1, 2016
Two key Georgia technology leaders are playing a pivotal role in the advancement of the large-scale manufacturing of cell-based therapeutics that can treat a wide range of serious illnesses. The Georgia Institute of Technology (Georgia Tech) – a fellow Midtown neighbor – and the Georgia Research Alliance (GRA) have joined forces to launch the National Cell Manufacturing Consortium (NCMC), an industry-academic-government partnership that recently released the National Roadmap for Advanced Cell Manufacturing. The roadmap was announced June 13 at the White House Organ Summit.
To learn how Georgia is positioning itself to be at the forefront of this emerging growth industry with revenues over $1 billion, read the full article, “Roadmap for Advanced Cell Manufacturing Shows Path to Cell-Based Therapeutics.”
For information on Smith & Howard’s manufacturing accounting services, please contact us at 404.874.6244 or simply fill out the form below.
If you have any questions and would like to connect with a team member please call 404-874-6244 or contact an advisor below.CONTACT AN ADVISOR
Subscribe to our newsletters to get inside access to timely news, trends and insights from Smith + Howard.